Key result
Pacemaker-measured maximum RDI ≥63 episodes/h is linked to ~74% higher risk of atrial fibrillation.
Why the study?
Sleep apnea is a risk factor for AF, and advanced pacemakers can calculate indexes of sleep apnea severity, but their predictive value for AF occurrence, stroke, and death needed evaluation.
Cohort (n=439)
Effect estimate: HR 1.74 (95% CI 1.22-2.48)
p-value: p=.001
Pacemaker-derived continuous monitoring of sleep-disordered breathing identifies patients at higher risk for incident atrial fibrillation and subsequent stroke or death.
May refine AF risk stratification in device patients; hypothesis-generating for SDB intervention trials.
BACKGROUND: Sleep apnea (SA) is a risk factor for atrial fibrillation (AF). Advanced pacemakers are now able to calculate indexes of SA severity. HYPOTHESIS: We investigated the changes in pacemaker-measured indexes of SA, we assessed their predictive value for AF occurrence and the associated risk of stroke and death at long-term. METHODS: We enrolled 439 recipients of a pacemaker endowed with an algorithm for the calculation of a Respiratory Disturbance Index (RDI). The RDI variability was measured over the first 12 months after implantation, as well as its potential association with the occurrence of AF, defined as device-detected cumulative AF burden ≥6 hoursours in a day. RESULTS: The individual RDI mean was 30 ± 18 episodes/h, and the RDI maximum was 59 ± 21 episodes/h. RDI ≥30 episodes/h was detected in 351 (80%) patients during at least one night. The proportion of nights with RDI ≥30 episodes/h was 14% (2%-36%). AF ≥6 hours was detected in 129 (29%) patients during the first 12 months. The risk of AF was higher in patients with RDI maximum ≥63 episodes/h (HR:1.74; 95%CI: 1.22-2.48; P = .001) and with RDI mean ≥ 46 episodes/h (HR:1.63; 95%CI: 1.03-2.57; P = .014). The risk of all-cause death or stroke was higher in patients with AF burden ≥6 hours (HR:1.75; 95%CI: 1.06-2.86; P = .016). Moreover, among patients with no previous history of AF the risk was higher in those with RDI maximum ≥63 episodes/h (HR:1.96; 95%CI: 1.06-3.63; P = .031). CONCLUSIONS: Pacemaker-detected SA showed a considerable variability during follow-up. We confirmed the association between RDI and higher risk of AF, and we observed an association between higher RDI maximum and all-cause death or stroke among patients with no previous history of AF.
No takes yet. Share an insight, caveat, or question.
Mazza et al. (2020) conducted a cohort in Pacemaker recipients (n=439). Pacemaker-measured Respiratory Disturbance Index (RDI) vs. Lower RDI was evaluated on Occurrence of atrial fibrillation (device-detected cumulative AF burden ≥6 hours in a day) (HR 1.74, 95% CI 1.22-2.48, p=.001). Pacemaker-measured maximum Respiratory Disturbance Index ≥63 episodes/h was associated with a higher risk of atrial fibrillation (HR 1.74; 95% CI 1.22-2.48; P=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: